Axon Partners Group SA
MAD:APG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Axon Partners Group SA
MAD:APG
|
ES |
|
Pangaea Oncology SA
MAD:PANG
|
ES |
|
Kuniko Ltd
ASX:KNI
|
AU |
|
D
|
Delta Gold Technologies PLC
OTC:DGQTF
|
UK |
|
S
|
Suzhou K-Hiragawa Electronic Technology Co Ltd
SSE:603052
|
CN |
Balance Sheet
Balance Sheet Decomposition
Axon Partners Group SA
Axon Partners Group SA
Balance Sheet
Axon Partners Group SA
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
4
|
3
|
6
|
10
|
8
|
10
|
|
| Cash |
0
|
0
|
0
|
0
|
8
|
10
|
|
| Cash Equivalents |
4
|
3
|
6
|
10
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Receivables |
4
|
3
|
4
|
5
|
6
|
4
|
|
| Accounts Receivables |
4
|
3
|
4
|
5
|
5
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
8
|
6
|
11
|
16
|
14
|
15
|
|
| PP&E Net |
3
|
3
|
3
|
0
|
0
|
0
|
|
| PP&E Gross |
3
|
3
|
3
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
1
|
1
|
1
|
1
|
1
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
2
|
2
|
|
| Long-Term Investments |
8
|
7
|
10
|
7
|
13
|
16
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
20
N/A
|
18
-10%
|
25
+38%
|
24
-2%
|
30
+24%
|
34
+12%
|
|
| Liabilities | |||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
2
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
1
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
1
|
2
|
1
|
2
|
2
|
|
| Total Current Liabilities |
3
|
3
|
5
|
3
|
5
|
5
|
|
| Long-Term Debt |
1
|
2
|
2
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
2
|
2
|
3
|
2
|
2
|
2
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
2
|
1
|
|
| Total Liabilities |
9
N/A
|
8
-9%
|
10
+34%
|
7
-29%
|
10
+30%
|
9
-6%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Retained Earnings |
6
|
6
|
8
|
7
|
9
|
11
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
11
|
9
|
9
|
|
| Unrealized Security Profit/Loss |
5
|
4
|
6
|
3
|
4
|
5
|
|
| Treasury Stock |
0
|
0
|
0
|
5
|
3
|
2
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
12
N/A
|
10
-11%
|
14
+41%
|
17
+17%
|
20
+21%
|
25
+20%
|
|
| Total Liabilities & Equity |
20
N/A
|
18
-10%
|
25
+38%
|
24
-2%
|
30
+24%
|
34
+12%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
5
|
5
|
5
|
5
|
5
|
5
|
|